Archives des Publications - Page 6 sur 11

Flexible Buprenorphine/Naloxone Model of Care for Reducing Opioid Use in Individuals With Prescription-Type Opioid Use Disorder: An Open-Label, Pragmatic, Noninferiority Randomized Controlled Trial

Jutras-Aswad, D., Le Foll, B., Ahamad, K., Lim, R., Bruneau, J., Fischer, B., Rehm, J., Wild, C., Wood, E., Brissette, S., Gagnon, L., Fikowski, J., Ledjiar, O., Masse, B., Socias, E. American Journal of Psychiatry, Volume 179, Number 10, https://doi.org/10.1176/appi.ajp.21090964 CONSULTER

Flexible Buprenorphine/Naloxone Model of Care for Reducing Opioid Use in Individuals With Prescription-Type Opioid Use Disorder: An Open-Label, Pragmatic, Noninferiority Randomized Controlled Trial Lire la suite »

Impact of fentanyl use on initiation and discontinuation of methadone and buprenorphine/naloxone among people with prescription-type opioid use disorder: secondary analysis of a Canadian treatment trial

Publications / ICRIS Québec

Socias, E., Wood, E., Le Foll, B., Lim, R., Cheol Choi, J., Yin Mok, W., Bruneau, J., Rehm, J., Wild, C., Bozinoff, N., Hassan, A., Jutras-Aswad, D. Addiction. 2022 Oct;117(10):2662-2672. doi: 10.1111/add.15954. Epub 2022 Jun 17. PMID: 35712892; PMCID: PMC9969999. CONSULTER

Impact of fentanyl use on initiation and discontinuation of methadone and buprenorphine/naloxone among people with prescription-type opioid use disorder: secondary analysis of a Canadian treatment trial Lire la suite »

Patient Satisfaction With Standard Methadone and Flexible Buprenorphine/Naloxone Models of Care: Results From a Pragmatic Randomized Controlled Clinical Trial

Publications / ICRIS Québec

Hassan, Ahmed N. MD, FRCPC, MPH; Bozinoff, Nikki MD, MSc, CCFP; Jutras-Aswad, Didier MD, MSc, FRCPC; Socias, M. Eugenia MD, MSc; Stewart, Sherry H. PhD; Lim, Ron MD, CCFP, DFASAM; Le Foll, Bernard MD, PhD, MCFP; The OPTIMA Research Group. Journal of Addiction Medicine 17(1):p e49-e56, 1/2 2023. | DOI: 10.1097/ADM.0000000000001048 CONSULTER

Patient Satisfaction With Standard Methadone and Flexible Buprenorphine/Naloxone Models of Care: Results From a Pragmatic Randomized Controlled Clinical Trial Lire la suite »

Buprenorphine/naloxone and methadone effectiveness for reducing craving in individuals with prescription opioid use disorder: Exploratory results from an open-label, pragmatic randomized controlled trial

Publications / ICRIS Québec

McAnulty, C., Bastien, G., Socias, E., Bruneau, J., Le Foll, B., Lim, R., Brissette, S., Ledjiar, O., Marsan, S., Talbot, A., Jutras-Aswad, D. Drug and Alcohol Dependence 239 (2022) 109604 CONSULTER

Buprenorphine/naloxone and methadone effectiveness for reducing craving in individuals with prescription opioid use disorder: Exploratory results from an open-label, pragmatic randomized controlled trial Lire la suite »

Changes in Hepatic Steatosis Before and After Direct-Acting Antiviral Treatment in People With HIV and Hepatitis C Coinfection

Publications / ICRIS Québec

Esther Truscello, Shouao Wang, Jim Young, Giada Sebastiani, Sharon L. Walmsley, Mark Hull, Curtis Cooper, Marina B. Klein J Infect Dis. 2025 Feb 4;231(1):e101-e112. doi: 10.1093/infdis/jiae487. PMID: 39417816; PMCID: PMC11793071.

Changes in Hepatic Steatosis Before and After Direct-Acting Antiviral Treatment in People With HIV and Hepatitis C Coinfection Lire la suite »

Brief Report: Intact Cognitive Functions in Children and Adolescents of Parents With Mood Disorders

Publications / ICRIS Québec

Boisvert M, Dugré JR, Potvin S. Early Interv Psychiatry. 2025 Apr;19(4):e70042. doi: 10.1111/eip.70042. PMID: 40229975; PMCID: PMC11997297 CONSULTER

Brief Report: Intact Cognitive Functions in Children and Adolescents of Parents With Mood Disorders Lire la suite »

Scapegoated communities, shared struggles: A call for solidarity with people who use drugs and queer and trans people

Publications / ICRIS Québec

London-Nadeau K, Barborini C, Haines-Saah R, Bazarov M, Bristowe S, Khorkhordina M, Lemay-Gaulin M, Gorka C, Juster RP, D’Alessio H, Chadi N. Int J Drug Policy. 2025 Sep;143:104915. doi: 10.1016/j.drugpo.2025.104915. Epub 2025 Jul 8. PMID: 40633507.

Scapegoated communities, shared struggles: A call for solidarity with people who use drugs and queer and trans people Lire la suite »

Classes of outpatient quality of care among individuals with substance-related disorders, based on a survey and health insurance registry

Publications / ICRIS Québec

Fleury MJ, Cao Z, Grenier G, Huỳnh C, Meng X. J Subst Use Addict Treat. 2025 Mar;170:209619. doi: 10.1016/j.josat.2024.209619. Epub 2025 Jan 2. PMID: 39755156 CONSULTER

Classes of outpatient quality of care among individuals with substance-related disorders, based on a survey and health insurance registry Lire la suite »

Navigating cannabis use during pregnancy: life trajectories, relationships, and contextual influences

Publications / ICRIS Québec

Alunni-Menichini K, Chabot R, Guilbert-Gauthier G, Dominguez-Cancino KA, Robidoux L, L’Espérance N, Huynh C, Bertrand K, Vasilidis HM, Loslier J, de Saugy YF, Martínez P, Massamba V, Nazif-Munoz JI. Sex Reprod Healthc. 2025 Sep;45:101129. doi: 10.1016/j.srhc.2025.101129. Epub 2025 Jul 20. PMID: 40701112.

Navigating cannabis use during pregnancy: life trajectories, relationships, and contextual influences Lire la suite »

Primary care physician characteristics associated with becoming opioid agonist treatment prescribers in British Columbia: a retrospective case-control study

Publications / ICRIS Québec

Panagiotoglou D, Peterson S, Lavergne MR, Gomes T, Chadha R, Johnson C, McCracken R. Harm Reduct J. 2025 Jun 25;22(1):111. doi: 10.1186/s12954-025-01261-5. PMID: 40563109; PMCID: PMC12199528.

Primary care physician characteristics associated with becoming opioid agonist treatment prescribers in British Columbia: a retrospective case-control study Lire la suite »

Publications

Flexible Buprenorphine/Naloxone Model of Care for Reducing Opioid Use in Individuals With Prescription-Type Opioid Use Disorder: An Open-Label, Pragmatic, Noninferiority Randomized Controlled Trial

Impact of fentanyl use on initiation and discontinuation of methadone and buprenorphine/naloxone among people with prescription-type opioid use disorder: secondary analysis of a Canadian treatment trial

Patient Satisfaction With Standard Methadone and Flexible Buprenorphine/Naloxone Models of Care: Results From a Pragmatic Randomized Controlled Clinical Trial

Buprenorphine/naloxone and methadone effectiveness for reducing craving in individuals with prescription opioid use disorder: Exploratory results from an open-label, pragmatic randomized controlled trial

Changes in Hepatic Steatosis Before and After Direct-Acting Antiviral Treatment in People With HIV and Hepatitis C Coinfection

Brief Report: Intact Cognitive Functions in Children and Adolescents of Parents With Mood Disorders

Scapegoated communities, shared struggles: A call for solidarity with people who use drugs and queer and trans people

Classes of outpatient quality of care among individuals with substance-related disorders, based on a survey and health insurance registry

Navigating cannabis use during pregnancy: life trajectories, relationships, and contextual influences

Primary care physician characteristics associated with becoming opioid agonist treatment prescribers in British Columbia: a retrospective case-control study

MENU

CONTACT

Centre de Recherche du CHUM

Téléphone

Courriel